vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and PRICESMART INC (PSMT). Click either name above to swap in a different company.
PRICESMART INC is the larger business by last-quarter revenue ($1.4B vs $950.5M, roughly 1.5× Astrana Health, Inc.). PRICESMART INC runs the higher net margin — 2.9% vs 0.7%, a 2.2% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 9.9%). PRICESMART INC produced more free cash flow last quarter ($32.6M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 3.5%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
PRICESMART INCPSMTEarnings & Financial Report
PriceSmart, Inc. is a United States based operator of membership warehouse clubs in Central America, the Caribbean, and South America. PriceSmart was founded by Sol and Robert Price, founders of Price Club; Robert Price is chairman of the board.
ASTH vs PSMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.4B |
| Net Profit | $6.6M | $40.2M |
| Gross Margin | — | 17.7% |
| Operating Margin | 1.9% | 4.6% |
| Net Margin | 0.7% | 2.9% |
| Revenue YoY | 42.9% | 9.9% |
| Net Profit YoY | 184.4% | 7.3% |
| EPS (diluted) | $0.12 | $1.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $1.4B | ||
| Q3 25 | $956.0M | $1.3B | ||
| Q2 25 | $654.8M | $1.3B | ||
| Q1 25 | $620.4M | $1.4B | ||
| Q4 24 | $665.2M | $1.3B | ||
| Q3 24 | $478.7M | $1.2B | ||
| Q2 24 | $486.3M | $1.2B | ||
| Q1 24 | $404.4M | $1.3B |
| Q4 25 | $6.6M | $40.2M | ||
| Q3 25 | $373.0K | $31.5M | ||
| Q2 25 | $9.4M | $35.2M | ||
| Q1 25 | $6.7M | $43.8M | ||
| Q4 24 | $-7.8M | $37.4M | ||
| Q3 24 | $16.1M | $29.1M | ||
| Q2 24 | $19.2M | $32.5M | ||
| Q1 24 | $14.8M | $39.3M |
| Q4 25 | — | 17.7% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 17.1% | ||
| Q4 24 | — | 17.4% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 1.9% | 4.6% | ||
| Q3 25 | 2.0% | 4.0% | ||
| Q2 25 | 3.1% | 4.3% | ||
| Q1 25 | 3.3% | 4.8% | ||
| Q4 24 | 0.1% | 4.6% | ||
| Q3 24 | 5.9% | 4.0% | ||
| Q2 24 | 6.2% | 4.1% | ||
| Q1 24 | 7.5% | 4.9% |
| Q4 25 | 0.7% | 2.9% | ||
| Q3 25 | 0.0% | 2.4% | ||
| Q2 25 | 1.4% | 2.7% | ||
| Q1 25 | 1.1% | 3.2% | ||
| Q4 24 | -1.2% | 3.0% | ||
| Q3 24 | 3.4% | 2.4% | ||
| Q2 24 | 3.9% | 2.6% | ||
| Q1 24 | 3.7% | 3.0% |
| Q4 25 | $0.12 | $1.29 | ||
| Q3 25 | $0.01 | $1.02 | ||
| Q2 25 | $0.19 | $1.14 | ||
| Q1 25 | $0.14 | $1.45 | ||
| Q4 24 | $-0.14 | $1.21 | ||
| Q3 24 | $0.33 | $0.94 | ||
| Q2 24 | $0.40 | $1.08 | ||
| Q1 24 | $0.31 | $1.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $320.6M |
| Total DebtLower is stronger | — | $180.3M |
| Stockholders' EquityBook value | $779.3M | $1.3B |
| Total Assets | $2.2B | $2.4B |
| Debt / EquityLower = less leverage | — | 0.14× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $320.6M | ||
| Q3 25 | $463.4M | $314.2M | ||
| Q2 25 | $342.1M | $262.4M | ||
| Q1 25 | $260.9M | $247.3M | ||
| Q4 24 | $290.8M | $222.2M | ||
| Q3 24 | $350.3M | $225.5M | ||
| Q2 24 | $327.7M | $228.2M | ||
| Q1 24 | $337.3M | $264.2M |
| Q4 25 | — | $180.3M | ||
| Q3 25 | — | $186.6M | ||
| Q2 25 | — | $103.1M | ||
| Q1 25 | — | $107.1M | ||
| Q4 24 | — | $115.6M | ||
| Q3 24 | — | $130.4M | ||
| Q2 24 | — | $135.1M | ||
| Q1 24 | — | $140.0M |
| Q4 25 | $779.3M | $1.3B | ||
| Q3 25 | $775.5M | $1.2B | ||
| Q2 25 | $765.5M | $1.2B | ||
| Q1 25 | $745.4M | $1.2B | ||
| Q4 24 | $712.7M | $1.2B | ||
| Q3 24 | $704.6M | $1.1B | ||
| Q2 24 | $678.9M | $1.1B | ||
| Q1 24 | $653.5M | $1.1B |
| Q4 25 | $2.2B | $2.4B | ||
| Q3 25 | $2.2B | $2.3B | ||
| Q2 25 | $1.4B | $2.1B | ||
| Q1 25 | $1.3B | $2.1B | ||
| Q4 24 | $1.4B | $2.1B | ||
| Q3 24 | $1.3B | $2.0B | ||
| Q2 24 | $1.3B | $2.0B | ||
| Q1 24 | $1.2B | $2.0B |
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.13× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $71.2M |
| Free Cash FlowOCF − Capex | $-6.0M | $32.6M |
| FCF MarginFCF / Revenue | -0.6% | 2.4% |
| Capex IntensityCapex / Revenue | 0.3% | 2.8% |
| Cash ConversionOCF / Net Profit | -0.44× | 1.77× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $125.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $71.2M | ||
| Q3 25 | $10.0M | $82.1M | ||
| Q2 25 | $90.9M | $52.8M | ||
| Q1 25 | $16.6M | $87.9M | ||
| Q4 24 | $-10.9M | $38.5M | ||
| Q3 24 | $34.0M | $41.8M | ||
| Q2 24 | $23.2M | $38.1M | ||
| Q1 24 | $6.0M | $86.6M |
| Q4 25 | $-6.0M | $32.6M | ||
| Q3 25 | $7.4M | $25.6M | ||
| Q2 25 | $89.5M | $14.0M | ||
| Q1 25 | $13.6M | $53.2M | ||
| Q4 24 | $-13.5M | $10.3M | ||
| Q3 24 | $31.7M | $15.2M | ||
| Q2 24 | $20.4M | $-308.0K | ||
| Q1 24 | $5.6M | $16.4M |
| Q4 25 | -0.6% | 2.4% | ||
| Q3 25 | 0.8% | 1.9% | ||
| Q2 25 | 13.7% | 1.1% | ||
| Q1 25 | 2.2% | 3.9% | ||
| Q4 24 | -2.0% | 0.8% | ||
| Q3 24 | 6.6% | 1.2% | ||
| Q2 24 | 4.2% | -0.0% | ||
| Q1 24 | 1.4% | 1.3% |
| Q4 25 | 0.3% | 2.8% | ||
| Q3 25 | 0.3% | 4.2% | ||
| Q2 25 | 0.2% | 2.9% | ||
| Q1 25 | 0.5% | 2.5% | ||
| Q4 24 | 0.4% | 2.2% | ||
| Q3 24 | 0.5% | 2.2% | ||
| Q2 24 | 0.6% | 3.1% | ||
| Q1 24 | 0.1% | 5.4% |
| Q4 25 | -0.44× | 1.77× | ||
| Q3 25 | 26.69× | 2.60× | ||
| Q2 25 | 9.65× | 1.50× | ||
| Q1 25 | 2.48× | 2.01× | ||
| Q4 24 | — | 1.03× | ||
| Q3 24 | 2.11× | 1.44× | ||
| Q2 24 | 1.21× | 1.17× | ||
| Q1 24 | 0.40× | 2.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
PSMT
| Fresh Foods | $454.9M | 33% |
| Caribbean Operations Segment | $396.5M | 29% |
| Colombia Operations Segment | $204.1M | 15% |
| Hardlines | $162.6M | 12% |
| Softlines | $99.8M | 7% |
| ship Income Member | $24.5M | 2% |
| Health Services | $14.5M | 1% |
| Other Revenue And Income | $4.2M | 0% |
| United States Operations Segment | $510.0K | 0% |
| Export Sales | $359.0K | 0% |
